Development of Anticancer agents targeting glutamine metabolism
Other
Agency: University Grants CommissionRole: Principal Investigator
No Data Found
There is currently nothing to display here.
3-(3-oxoaryl) indoles as anti-cancer agents and a process of synthesis thereof
BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS)
PILANI
-
Patent No. :
41/2020
Filed :
01-04-2020
Published :
09-10-2020Published
3-(1H-INDOL-3-YL)-1,3-DIPHENYL PROPAN-1-ONE DERIVATIVES AS ANTI-CANCER AGENTS AND A PROCESS OF SYNTHESIS THEREOF
BIRLA INSTITUTE OF TECHNOLOGY & SCIENCE (BITS)
PILANI
-
Patent No. :
41/2020
Filed :
01-04-2020
Published :
09-10-2020Published
Scholarly Publications
Lymphatic drug targeting
Book Chapter
Year: 2016.
Pages: 161-179
.
Integrating regression and classification-based QSARs with molecular docking analyses to explore the structure-antiaromatase activity relationships of letrozole-based analogs
Identification of structural requirements and prediction of inhibitory activity of natural flavonoids against Zika virus through molecular docking and Monte Carlo based QSAR Simulation